We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+8.51%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$7.52B
AUM Growth
+$1.2B
Cap. Flow
+$726M
Cap. Flow %
9.65%
Top 10 Hldgs %
19.11%
Holding
866
New
79
Increased
318
Reduced
279
Closed
56

Top Buys

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$75M
2
BIIB icon
Biogen
BIIB
+$70.7M
3
REGN icon
Regeneron Pharmaceuticals
REGN
+$60.1M
4
MRK icon
Merck
MRK
+$54.6M
5
GILD icon
Gilead Sciences
GILD
+$33.1M

Top Sells

Rank Stock Value
1
AMD icon
Advanced Micro Devices
AMD
+$19.1M
2
IRBT
iRobot
IRBT
+$15.5M
3
DGX icon
Quest Diagnostics
DGX
+$15.4M
4
CL icon
Colgate-Palmolive
CL
+$14.8M
5
PM icon
Philip Morris
PM
+$12.3M

Sector Composition

Rank Sector Weight
1 Healthcare 33.26%
2 Technology 16.05%
3 Financials 11.26%
4 Consumer Discretionary 7.98%
5 Communication Services 7.66%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GG
326
DELISTED
Goldcorp Inc
GG
$4.76M 0.06%
467,434
+5,711
+1% +$66.9K
HPQ icon
327
HP
HPQ
$24.2B
$4.72M 0.06%
183,038
+5,156
+3% +$125K
PPLI
328
People Inc
PPLI
$3.15B
$4.7M 0.06%
+121,252
New +$3.94M
IPGP icon
329
IPG Photonics
IPGP
$3.81B
$4.64M 0.06%
29,718
-5,956
-17% -$1.11M
AFSI
330
DELISTED
AmTrust Financial Services, Inc.
AFSI
$4.61M 0.06%
+317,564
New +$4.62M
CDK
331
DELISTED
CDK Global, Inc.
CDK
$4.6M 0.06%
73,582
+62,961
+593% +$3.99M
KMB icon
332
Kimberly-Clark
KMB
$36.9B
$4.57M 0.06%
40,193
-9,255
-19% -$1.04M
LECO icon
333
Lincoln Electric
LECO
$14B
$4.55M 0.06%
+48,659
New +$4.5M
NAVG
334
DELISTED
Navigators Group Inc
NAVG
$4.49M 0.06%
+65,000
New +$4.16M
WYNN icon
335
Wynn Resorts
WYNN
$10.4B
$4.49M 0.06%
35,300
+27,826
+372% +$4.13M
PKG icon
336
Packaging Corp of America
PKG
$22.4B
$4.46M 0.06%
40,632
+19,053
+88% +$2.15M
AHL
337
DELISTED
ASPEN Insurance Holding Limited
AHL
$4.46M 0.06%
+106,600
New +$4.26M
DRNA
338
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
$4.45M 0.06%
+291,500
New +$4.24M
WEB
339
DELISTED
Web.com Group, Inc.
WEB
$4.44M 0.06%
+159,000
New +$4.29M
MAS icon
340
Masco
MAS
$16.3B
$4.41M 0.06%
120,536
+47,405
+65% +$1.82M
SWX icon
341
Southwest Gas
SWX
$6.68B
$4.38M 0.06%
+55,394
New +$4.38M
PTLA
342
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
$4.38M 0.06%
164,300
+18,600
+13% +$607K
ZTS icon
343
Zoetis
ZTS
$32.3B
$4.37M 0.06%
47,687
-1,056
-2% -$93.7K
AIG icon
344
American International
AIG
$42.1B
$4.35M 0.06%
81,723
-1,905
-2% -$102K
KEY icon
345
KeyCorp
KEY
$24.2B
$4.33M 0.06%
217,641
SPG icon
346
Simon Property Group
SPG
$74.7B
$4.29M 0.06%
24,288
+1,066
+5% +$189K
EW icon
347
Edwards Lifesciences
EW
$48.3B
$4.28M 0.06%
73,818
-783
-1% -$38.3K
BLK icon
348
Blackrock
BLK
$164B
$4.27M 0.06%
9,056
-1,999
-18% -$972K
RVNC
349
DELISTED
Revance Therapeutics, Inc.
RVNC
$4.25M 0.06%
171,000
BNY
350
Bank of New York Mellon
BNY
$107B
$4.25M 0.06%
83,296
-1,202
-1% -$63.2K

Similar funds

Candriam SCA's Q3 2018 Portfolio in Review

As of Q3 2018, Candriam SCA held 866 positions worth $7.52B, up 19% from $6.32B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Candriam SCA deployed $726M of net new capital in Q3 2018, opening 79 new positions and adding to 318 existing holdings. Its largest new stake was Varonis Systems: 541,092 shares worth $13.2M.

By sector, the portfolio is most concentrated in Healthcare at 33% of assets, up from 25% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Advanced Micro Devices, an estimated $19.1M trimmed.

  • Candriam SCA's largest Q3 2018 buy was Varonis Systems: 541,092 shares worth $13.2M.
  • Candriam SCA added most to Amgen in Q3 2018, an estimated $75M increase.
  • Candriam SCA's biggest Q3 2018 reduction was Advanced Micro Devices, cutting an estimated $19.1M.
  • Candriam SCA fully exited iRobot in Q3 2018, selling an estimated $15.5M.
  • Candriam SCA's ten largest holdings make up 19% of its $7.52B portfolio in Q3 2018.
  • Candriam SCA opened 79 new positions and closed 56 in Q3 2018.
  • Candriam SCA's portfolio value rose 19% quarter-over-quarter to $7.52B.

Based on Candriam SCA's 13F filing for Q3 2018, filed 7 Nov 2018.